Risk-based Monitoring Software Market

Risk-based Monitoring Software Market by End User (Pharma & Biopharmaceutical Co., Medical Device Co., CROs), Delivery Mode (Web Hosted, On-premise, Cloud-based), Type (Enterprise, Site), Component (Software, Services) - Global Forecast to 2025

Report Code: HIT 7651 May, 2020, by marketsandmarkets.com

[137 Pages Report] The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% during the forecast period. Growth in the RBM software market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials. However, the high implementation cost of RBM solutions is expected to restrain the growth of this market during the forecast period.

Risk-based Monitoring Software Market

The software component segment is expected to command the largest market share in 2020.

Based on the component, the RBM software market is segmented into Software and Services. In 2020, the software segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to can be attributed to the increasing R&D expenditure in the life science and clinical research industries, an increasing number of clinical trials, and rising customer base

The Web-based (On-demand) delivery mode segment is expected to command the largest market share e in 2020.

Based on delivery mode, the RBM software market is segmented into Web-based (On-demand), Licensed Enterprise (On-premise), and Cloud-based (SaaS). In 2020, the Web-based (On-demand) segment is expected to command the largest share of the RBM software market. The large share of this segment can be attributed to the advantages offered by web-based software, such as easy access, improved productivity, time efficiency, and cost-efficiency.

The pharmaceutical and biopharmaceutical companies segment to hold the largest market share in 2020.

Based on end user, the RBM software market is segmented into pharmaceutical and biopharmaceutical companies, CROs, medical device companies, and other end users. In 2020, the pharmaceutical and biopharmaceutical companies segment is expected to command the largest share of the RBM software market. The increasing R&D expenditure of pharmaceutical and biopharmaceutical companies is the major factor driving the growth of this end-user segment.

Risk-based Monitoring Software Market

North America accounted for the largest share of the RBM software market in 2020, while the Asia Pacific market is expected to register the highest growth during the forecast period

Geographically, the North American market is expected to account for the largest share of the global RBM software market. The Asia Pacific market is expected to grow at the highest CAGR in the forecast period. This growth can be attributed to increasing government funding to support clinical trials, the presence of less stringent regulatory guidelines as compared to developed nations, a large patient base, low operating costs for conducting clinical trials, shortage of trial volunteers in Europe and North America, and the growing number of pharmaceutical companies and CROs in the region

Key Market Players

Oracle (US), Medidata Solutions (US), and Parexel (US). Other prominent players in the market are Bioclinica (US), Bio-Optronics (US), IBM Corporation (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), Anju Software (US), MaxisIT (US), Techsol Corporation (US), OpenClinica (US), CRF Health (US), and Covance (US).

Scope of the Report

Report Metric

Details

Market size available for years

2018–2025

Base year considered

2019

Forecast period

2020–2025

Forecast unit

Value (USD)

Segments covered

Type, Component, Delivery Mode, End User, and Region

Geographies covered

North America (US & Canada), Europe (Germany, UK, France, RoE), Asia Pacific (China, Japan, India, RoAPAC), and RoW

Companies covered

Major 20 players included, including Oracle (US), Medidata Solutions (US), Parexel (US), Bioclinica (US), Bio-Optronics (US), IBM Corporation (US), DATATRAK (US), Veeva Systems (US), DSG (US), MasterControl (US), ERT (US), Forte Research Systems (US), MedNet Solutions (US), ArisGlobal (US), Anju Software (US), MaxisIT (US), Techsol Corporation (US), OpenClinica (US), CRF Health (US), and Covance (US).

This research report categorizes the RBM software market based on type, application, procedural volume, and country.

By Type

  • Enterprise RBM Software
  • Site RBM Software

By Component

  • Software
  • Services

By Delivery Mode

  • Web-based (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based (SaaS)

By End-User

  • Pharmaceutical & Biopharmaceutical Companies
  • CROs
  • Medical Device Companies
  • Other End Users

By Region

  •  North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  •  Asia Pacific
    • China
    •  Japan
    •  India
    •  RoAPAC
  • RoW

Recent developments:

  • In 2018, Bioclinica (US) launched the SMART technology suite available with Medical Imaging, Electronic Data Capture (EDC), and Interactive Response Technology (IRT) combined.
  • In 2019, Veeva Systems (US), acquired Crossix Solutions (US), a provider of privacy-safe US patient data and best-in-class analytics platform to help maximize media and marketing effectiveness.
  • In 2019, Parexel International Corporation (US), partnered with Datavant (US) to enable the connection of real-world data across all clinical trials conducted by Parexel.

Key Questions Addressed by the Report:

  • Which segment will dominate the RBM software market in the future?
  • Which end-user segment will dominate the RBM software market in the future?
  • Emerging countries offer immense opportunities for the growth and adoption of RBM software; will this scenario continue in the coming five years?
  • Where will all the advancements in technology offered by various companies take the industry in the mid- to long-term?
  • What are the upcoming products in the RBM software market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 17)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 MARKET SCOPE
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 20)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Primary sources
           2.1.3 MARKET SIZE ESTIMATION METHODOLOGY
           2.1.4 REVENUE MAPPING-BASED MARKET ESTIMATION (APPROACH 1)
           2.1.5 MARKET ESTIMATION USING PARENT MARKET SIZE (APPROACH 2)
    2.2 MARKET DATA ESTIMATION AND TRIANGULATION
    2.3 ASSUMPTIONS OF THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 30)

4 PREMIUM INSIGHTS (Page No. - 34)
    4.1 RISK-BASED MONITORING SOFTWARE: MARKET OVERVIEW
    4.2 RISK-BASED MONITORING SOFTWARE MARKET SHARE, BY TYPE, 2020 VS. 2025
    4.3 RISK-BASED MONITORING SOFTWARE MARKET SHARE,  BY COMPONENT, 2020 VS. 2025
    4.4 RISK-BASED MONITORING SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW (Page No. - 36)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Cost and time efficiency of RBM solutions
                    5.2.1.2 Rising number of clinical trials
                    5.2.1.3 Increasing government funding and grants to support clinical trials
           5.2.2 RESTRAINTS
                    5.2.2.1 High implementation costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increased outsourcing of clinical trial processes to CROs
           5.2.4 CHALLENGES
                    5.2.4.1 Dearth of skilled professionals for operating RBM solutions

6 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE (Page No. - 40)
    6.1 INTRODUCTION
    6.2 ENTERPRISE RBM SOFTWARE
           6.2.1 ENTERPRISE RBM SOFTWARE DOMINATES THE RBM SOFTWARE MARKET
    6.3 SITE RBM SOFTWARE
           6.3.1 SITE RBM SOFTWARE OFFERS IMPROVED TRIAL MANAGEMENT

7 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT (Page No. - 45)
    7.1 INTRODUCTION
    7.2 SOFTWARE
           7.2.1 GROWING ADOPTION OF CLINICAL TRIAL MANAGEMENT SOLUTIONS TO SUPPORT MARKET GROWTH
    7.3 SERVICES
           7.3.1 NEED FOR CONTINUOUS UPGRADE OF RBM SOFTWARE PRODUCTS HAS INCREASED THE DEMAND FOR SERVICES

8 RISK-BASED MONITORING SOFTWARE MARKET,  BY DELIVERY MODE (Page No. - 50)
    8.1 INTRODUCTION
    8.2 WEB-BASED (ON-DEMAND)
           8.2.1 ADVANTAGES SUCH AS EASY ACCESS & REDUCTION IN COSTS TO SUPPORT MARKET GROWTH
    8.3 LICENSED ENTERPRISE (ON-PREMISE)
           8.3.1 ON-PREMISE MODELS MINIMIZE RISKS ASSOCIATED WITH DATA BREACHES AND EXTERNAL ATTACKS
    8.4 CLOUD-BASED (SAAS)
           8.4.1 INCREASING ADOPTION OF CLOUD-BASED SOLUTIONS TO DRIVE MARKET GROWTH

9 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER (Page No. - 57)
    9.1 INTRODUCTION
    9.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
           9.2.1 INCREASED PHARMACEUTICAL R&D SPENDING TO DRIVE MARKET GROWTH
    9.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
           9.3.1 INCREASING OUTSOURCING OF CLINICAL RESEARCH ACTIVITIES  BY PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES TO DRIVE MARKET GROWTH
    9.4 MEDICAL DEVICE COMPANIES
           9.4.1 GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH
    9.5 OTHER END USERS

10 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION (Page No. - 66)
     10.1 INTRODUCTION
     10.2 NORTH AMERICA
             10.2.1 US
                        10.2.1.1 The US holds the largest share of the North American market
             10.2.2 CANADA
                        10.2.2.1 Government funding to boost market growth
     10.3 EUROPE
             10.3.1 GERMANY
                        10.3.1.1 Initiatives to boost digital health to propel market growth
             10.3.2 UK
                        10.3.2.1 Favorable R&D scenario in the country to boost the adoption of RBM software
             10.3.3 FRANCE
                        10.3.3.1 Lack of sufficient funding to restrain market growth in France
             10.3.4 ROE
     10.4 APAC
             10.4.1 CHINA
                        10.4.1.1 Increased pharmaceutical R&D spending to drive market growth
             10.4.2 JAPAN
                        10.4.2.1 Stringent regulatory scenario in Japan to restrain market growth
             10.4.3 INDIA
                        10.4.3.1 Favorable pharmaceutical R&D scenario to drive the adoption of RBM software
             10.4.4 REST OF ASIA PACIFIC
     10.5 REST OF THE WORLD

11 COMPETITIVE LANDSCAPE (Page No. - 96)
     11.1 OVERVIEW
     11.2 MARKET SHARE ANALYSIS
     11.3 COMPETITIVE LEADERSHIP MAPPING
             11.3.1 VISIONARY LEADERS
             11.3.2 INNOVATORS
             11.3.3 DYNAMIC DIFFERENTIATORS
             11.3.4 EMERGING COMPANIES
     11.4 COMPETITIVE SCENARIO
             11.4.1 PRODUCT LAUNCHES & ENHANCEMENTS
             11.4.2 FUNDING
             11.4.3 ACQUISITIONS
             11.4.4 PARTNERSHIPS
             11.4.5 COLLABORATIONS

12 COMPANY PROFILES (Page No. - 103)
     12.1 ORACLE
     12.2 MEDIDATA SOLUTIONS
     12.3 PAREXEL (ACQUIRED BY PAMPLONA CAPITAL MANAGEMENT)
     12.4 BIOCLINICA
     12.5 BIO-OPTRONICS
     12.6 IBM
     12.7 DATATRAK
     12.8 VEEVA SYSTEMS
     12.9 DSG
     12.10 MASTERCONTROL
     12.11 ERT
     12.12 FORTE RESEARCH SYSTEMS
     12.13 MEDNET SOLUTIONS
     12.14 ARISGLOBAL
     12.15 ANJU SOFTWARE
     12.16 AXISIT
     12.17 TECHSOL CORPORATION
     12.18 OPENCLINICA
     12.19 CRF HEALTH
     12.20 COVANCE INC.

13 APPENDIX (Page No. - 131)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS


LIST OF TABLES (114 Tables)

TABLE 1 NUMBER OF REGISTERED CLINICAL TRIAL STUDIES GLOBALLY, 2002–2019
TABLE 2 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 3 ENTERPRISE RBM SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 5 EUROPE: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 6 ASIA PACIFIC: ENTERPRISE RBM SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 7 SITE RBM SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 NORTH AMERICA: SITE RBM SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 9 EUROPE: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 ASIA PACIFIC: SITE RBM SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 12 RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY REGION,  2018–2025 (USD MILLION)
TABLE 13 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SOFTWARE,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY REGION,  2018–2025 (USD MILLION)
TABLE 17 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR SERVICES,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 21 RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY,  BY REGION, 2018–2025 (USD MILLION)
TABLE 22 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR WEB-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY,  BY REGION, 2018–2025 (USD MILLION)
TABLE 26 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR LICENSED ENTERPRISE DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY,  BY REGION, 2018–2025 (USD MILLION)
TABLE 30 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CLOUD-BASED DELIVERY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 34 RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES,  BY REGION, 2018–2025 (USD MILLION)
TABLE 43 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)
TABLE 47 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER  END USERS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 49 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET FOR OTHER END USERS,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 RISK-BASED MONITORING SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 51 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 52 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT, 2018–2025 (USD MILLION)
TABLE 54 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 56 US: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 US: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 58 US: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 59 US: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 60 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 61 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 62 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 63 CANADA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 64 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 65 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 66 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 67 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 68 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 69 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 70 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 71 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 72 GERMANY: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 73 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 75 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 76 UK: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 77 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 78 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 79 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 80 FRANCE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 81 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 82 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 83 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 84 ROE: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 85 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 86 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 87 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 88 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 90 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 91 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 92 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 93 CHINA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 94 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 95 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 96 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 97 JAPAN: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 98 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 99 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 100 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 101 INDIA: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 102 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 103 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 104 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 105 ROAPAC: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 106 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 107 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2018–2025 (USD MILLION)
TABLE 108 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2018–2025 (USD MILLION)
TABLE 109 ROW: RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 110 KEY PRODUCT LAUNCHES & ENHANCEMENTS
TABLE 111 KEY FUNDING
TABLE 112 KEY ACQUISITIONS
TABLE 113 KEY PARTNERSHIPS
TABLE 114 KEY COLLABORATIONS


LIST OF FIGURES (30 Figures)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (1/2)
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2/2)
FIGURE 6 MARKET SIZE ESTIMATION BASED ON PARENT MARKET SIZE (APPROACH 2)
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 RISK-BASED MONITORING SOFTWARE MARKET, BY TYPE,  2020 VS. 2025 (USD MILLION)
FIGURE 9 RISK-BASED MONITORING SOFTWARE MARKET, BY COMPONENT,  2020 VS. 2025 (USD MILLION)
FIGURE 10 RISK-BASED MONITORING SOFTWARE MARKET, BY DELIVERY MODE,  2020 VS. 2025 (USD MILLION)
FIGURE 11 RISK-BASED MONITORING SOFTWARE MARKET, BY END USER,  2020 VS. 2025 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE RISK-BASED MONITORING SOFTWARE MARKET
FIGURE 13 RISING NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH
FIGURE 14 ENTERPRISE RBM SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE  THE RBM SOFTWARE MARKET IN 2025
FIGURE 15 SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
FIGURE 16 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE RBM SOFTWARE MARKET DURING THE FORECAST PERIOD
FIGURE 17 RISK-BASED MONITORING SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 18 NORTH AMERICA: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 19 EUROPE: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 20 APAC: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 21 ROW: RISK-BASED MONITORING SOFTWARE MARKET SNAPSHOT
FIGURE 22 KEY DEVELOPMENTS IN THE RISK-BASED MONITORING SOFTWARE MARKET
FIGURE 23 RISK-BASED MONITORING SOFTWARE MARKET SHARE ANALYSIS (2018)
FIGURE 24 RISK-BASED MONITORING SOFTWARE MARKET (GLOBAL): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 25 ORACLE: COMPANY SNAPSHOT (2018)
FIGURE 26 MEDIDATA SOLUTIONS: COMPANY SNAPSHOT (2018)
FIGURE 27 PAREXEL: COMPANY SNAPSHOT (2016)
FIGURE 28 IBM: COMPANY SNAPSHOT (2018)
FIGURE 29 DATATRAK: COMPANY SNAPSHOT (2018)
FIGURE 30 VEEVA SYSTEMS: COMPANY SNAPSHOT (2018)

The study involved four major activities in estimating the current size for the risk-based monitoring (RBM) software market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to, to identify and collect information for the RBM software market study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold standard & silver standard websites, regulatory bodies, and databases.

Primary Research

The RBM software market comprises several stakeholders such as RBM software vendors, healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies), medical device vendors/service providers, research institutes, and research and consulting firms. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. Mentioned below is the breakdown of primary respondents:

Risk-based Monitoring Software Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the RBM software market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall RBM software market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the RBM software industry

Report Objectives

  • To define, describe, and forecast the RBM software market based on type, component, delivery mode, end-user, and region
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall RBM software market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments concerning North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
  •  To strategically analyze the market structure and profile key players and their core competencies in the RBM software market

To track and analyze competitive developments such as product launches, expansions, acquisitions, partnerships, and collaborations in the RBM software market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the RBM software market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the software portfolios of the top five companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Risk-based Monitoring Software Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Risk-based Monitoring Software Market

Request For Special Pricing
Report Code
HIT 7651
Published ON
May, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Risk-based Monitoring Software Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home